Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $260,573 - $289,326
4,090 Added 11.28%
40,339 $2.58 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $49,019 - $55,599
746 Added 2.1%
36,249 $2.51 Million
Q4 2022

Jan 20, 2023

SELL
$68.48 - $81.09 $44,580 - $52,789
-651 Reduced 1.8%
35,503 $0
Q3 2022

Nov 03, 2022

BUY
$0.13 - $76.84 $278 - $164,668
2,143 Added 6.3%
36,154 $2.57 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $203,118 - $223,704
-2,797 Reduced 7.6%
34,011 $2.62 Million
Q1 2022

Apr 27, 2022

SELL
$61.48 - $73.72 $1.35 Million - $1.62 Million
-21,968 Reduced 37.38%
36,808 $2.69 Million
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $145,444 - $169,554
2,712 Added 4.84%
58,776 $3.67 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $186,503 - $218,465
3,152 Added 5.96%
56,064 $3.32 Million
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $224,114 - $244,060
3,620 Added 7.34%
52,912 $3.54 Million
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $56,313 - $63,336
-949 Reduced 1.89%
49,292 $3.11 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $402,678 - $456,308
6,974 Added 16.12%
50,241 $3.12 Million
Q3 2020

Oct 19, 2020

BUY
$57.43 - $63.64 $1.09 Million - $1.21 Million
19,007 Added 78.35%
43,267 $2.61 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $278,595 - $325,705
5,082 Added 26.5%
24,260 $1.43 Million
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $47,560 - $69,115
-1,025 Reduced 5.07%
19,178 $1.07 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $450,271 - $587,338
9,150 Added 82.78%
20,203 $1.3 Million
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $275,481 - $326,623
6,441 Added 139.66%
11,053 $560,000
Q2 2019

Aug 20, 2019

SELL
$44.62 - $49.34 $136,269 - $150,684
-3,054 Reduced 39.84%
4,612 $209,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $345,889 - $412,430
7,666 New
7,666 $366,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.